Received Aug 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Z002626 | IM / LA |
The PCV21 vaccine was given on 7/23 after discussion with the patient's primary doctor. On 7/28, patient presented to the clinic with an injection site reaction and concern for an allergic reaction to the vaccine. Per physician note on 7/28, "notably multiple separate, circumscribed areas would be unlikely to be an allergic reaction". The patient was given antibiotics with a plan to follow up in 2 days (no encounters happened per chart review).
Possible cellulitis of other specified vaccine injection site reactions. The patient was started on antibiotics for a possible skin and soft tissue infection (SSTI) with a plan to follow up after 2 days if no improvement. The patient did not follow up, assuming he improved. Reported the as a possible vaccine reaction vs SSTI
allergic rhinitis, hyperlipidemia, pre-diabetes, insomnia, dyspepsia, back pain
amoxicillin, clonazepam, multivitamins, simvastatin
Pollen
n/a